Exos Asset Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Exos Asset Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-88,354	Closed	-$8.84K	–	29
2024 Q4	$8.84K	Hold	88,354	–	–	2.04%	14
2024 Q3	$6.25K	Sell	88,354 -57,900	-40%	-$5.18K	0.61%	24
2024 Q2	$13.3K	Hold	146,254	–	–	0.02%	87
2024 Q1	$21.1K	Buy	+146,254	New	+$16.6K	0.01%	112
2021 Q4	–	Sell	-14,000	Closed	-$16K	–	388
2021 Q3	$16K	Buy	+14,000	New	+$17.5K	0.01%	384

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Exos Asset Management's NKGNW Position: Q1 2025 in Review

Exos Asset Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 88,354 shares — an estimated $8.84K sold.

Exos Asset Management first reported a position in NKGNW in Q3 2021 and held it in 5 quarters. The position peaked at $21.1K in Q1 2024. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

Exos Asset Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
Exos Asset Management sold 88,354 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $8.84K.
Exos Asset Management first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 5 quarters.
Exos Asset Management's NKGen Biotech, Inc. Warrants position peaked at $21.1K in Q1 2024.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Exos Asset Management's 13F filing for Q1 2025, filed 15 May 2025.